Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

VOLITIONRX LTD Director's Dealing 2015

Sep 15, 2015

34395_dirs_2015-09-15_ff1ef4f1-ce7c-4f87-b5d9-7e489efb74dd.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2014-08-18

Reporting Person: Faulkes Martin Charles (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-08-18 Option (Right to Buy) $2.5 A 30000 Acquired 2019-02-18 Common Stock (30000) Direct
2014-08-18 Option (Right to Buy) $3 A 30000 Acquired 2020-02-18 Common Stock (30000) Direct
2015-05-18 Option (Right to Buy) $3 D 5000 Disposed 2015-05-25 Common Stock (5000) Direct
2015-05-18 Option (Right to Buy) $3 D 5000 Disposed 2015-11-25 Common Stock (5000) Direct
2015-05-18 Option (Right to Buy) $4 D 5000 Disposed 2016-05-25 Common Stock (5000) Direct
2015-05-18 Option (Right to Buy) $4 D 5000 Disposed 2016-11-25 Common Stock (5000) Direct
2015-05-18 Option (Right to Buy) $5 D 5000 Disposed 2017-05-25 Common Stock (5000) Direct
2015-05-18 Option (Right to Buy) $5 D 5000 Disposed 2017-11-25 Common Stock (5000) Direct
2015-05-18 Option (Right to Buy) $3 A 5000 Acquired 2016-05-25 Common Stock (5000) Direct
2015-05-18 Option (Right to Buy) $3 A 5000 Acquired 2016-11-25 Common Stock (5000) Direct
2015-05-18 Option (Right to Buy) $4 A 5000 Acquired 2017-05-25 Common Stock (5000) Direct
2015-05-18 Option (Right to Buy) $4 A 5000 Acquired 2017-11-25 Common Stock (5000) Direct
2015-05-18 Option (Right to Buy) $5 A 5000 Acquired 2018-05-25 Common Stock (5000) Direct
2015-05-18 Option (Right to Buy) $5 A 5000 Acquired 2018-11-25 Common Stock (5000) Direct

Footnotes

F1: A total of 60,000 Options were granted on August 18, 2014 under the Company's 2011 Equity Incentive Plan. The Options vest in two equal installments at 6 months and at 18 months from the date of grant.

F2: The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the "old" options and the grant of "replacement" options. The "old" options were originally granted on November 25, 2011 and fully-vested on November 25, 2014, and were exercisable for three years from the date first exercisable. The "replacement" options are fully-vested and exercisable for a period of four years from the date first exercisable.